Paper Details

  1. Home
  2. Paper Details

WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Author: AdachiJ D, CranneyA, GuyattG, PapaioannouA, RobinsonV A, SheaB J, TugwellP, WaldeggerL M, WeaverB, WellsG, ZytarukN

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

After menopause, bones weaken, increasing the risk of fractures. Risedronate, a newer type of bisphosphonate, has been shown to reduce fracture risk and improve bone density in postmenopausal women with osteoporosis. Risedronate may be better tolerated than older bisphosphonates, which are known to cause gastrointestinal side effects.
Paper Details　
Original Abstract of the Article :
Postmenopausal osteoporosis results in an increased susceptibility to low-trauma fractures due to reduced bone volume and microarchitectural deterioration. Risedronate, a third generation bisphosphonate, has been shown in multiple clinical trials to reduce fracture risk and improve bone mineral dens...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD004523.pub2

データ提供：米国国立医学図書館（NLM）

Risedronate for Postmenopausal Osteoporosis: Strengthening Bones in a Fragile Landscape

This study explores the use of risedronate, a bisphosphonate medication, in preventing and treating postmenopausal osteoporosis, a condition characterized by weakened bones and increased fracture risk. The researchers investigated the effects of risedronate on bone mineral density and fracture risk in postmenopausal women with osteoporosis.

Building Stronger Foundations: Risedronate's Potential

The study found that risedronate effectively reduced fracture risk and improved bone mineral density in postmenopausal women with osteoporosis. This suggests that risedronate can be a valuable tool for strengthening bones and mitigating the risks associated with osteoporosis. Imagine a desert traveler building a sturdy shelter to protect themselves from the elements; risedronate can help build a stronger foundation for bones, reducing the risk of fractures.

Maintaining Bone Health: A Lifelong Journey

This study highlights the importance of maintaining bone health, particularly in postmenopausal women. It emphasizes the need for regular bone density screenings, a balanced diet rich in calcium and vitamin D, and a healthy lifestyle, including weight-bearing exercise. Just as a desert traveler needs to carefully conserve their resources, maintaining bone health requires a proactive approach to prevent osteoporosis and its associated risks.

Dr. Camel's Conclusion

This study offers valuable insights into the role of risedronate in managing postmenopausal osteoporosis. It highlights the importance of early intervention and a comprehensive approach to bone health, including medication, lifestyle modifications, and regular monitoring. Like a desert traveler who prepares for a challenging journey, maintaining bone health requires proactive measures and a commitment to a healthy lifestyle.
Date :
  1. Date Completed 2007-10-18
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

17636764

DOI: Digital Object Identifier

10.1002/14651858.CD004523.pub2

Related Literature

Article Analysis
・Effective treatment of osteoporosis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.